Announcements Trials
Browse Landscape

Phase

Phase 2 35Phase NA 9Phase 1/2 7Phase 1 7Phase EARLY_PHASE1 2Phase 4 2Phase 3 2Phase 2/3 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Endocrine 2CNS 2NET 1

Conditions

Neuroendocrine Tumors 18Pituitary Neoplasms 5Pheochromocytoma 3Insulinoma 3Thyroid Carcinoma, Anaplastic 2Pituitary ACTH Hypersecretion 2Paraganglioma 2Neuroblastoma 2Multiple Endocrine Neoplasia Type 1 2Meningioma 2Lung Neoplasms 2Kidney Neoplasms 2Carcinoma, Renal Cell 2Carcinoid Tumor 2Breast Neoplasms 2Adrenocortical Carcinoma 2Adrenal Gland Neoplasms 2von Hippel-Lindau Disease 1Vulvar Neoplasms 1Uterine Cervical Neoplasms 1Thyroid cancer, medullary 1Thyroid Cancer, Papillary 1Sexual Infantilism 1Serotonin Syndrome 1Sarcoma 1Recurrence 1Rectal Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neuroma, Acoustic 1

Interventions

gallium Ga 68 dotatate 13-fluorobenzylguanidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Paraganglioma × Endocrine × Clear all
NCT05636540 2026-02-27

In Vivo PARP-1 Expression With 18F-FluorThanatrace PET/CT in Patients With Pheochromocytoma and Paraganglioma

Abramson Cancer Center at Penn Medicine

Phase EARLY_PHASE1 Recruiting
30 enrolled
CNSEndocrine

Paraganglioma, Pheochromocytoma

NCT05069220 2024-03-01

18F-MFBG PET/CT in the Evaluation of Neural Crest Tumor

Peking Union Medical College Hospital

Phase EARLY_PHASE1 Recruiting
150 enrolled
CNSEndocrineNET

Neuroblastoma, Paraganglioma, Pheochromocytoma, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡